Nearly 80 percent of the state’s voters rejected the Drug Price Relief Act, which is designed to reduce prescription drug spending, according to the report. Under the ballot initiative, Ohio agencies, including the Medicaid department, would not be charged more for medicine than the U.S. Department of Veterans Affairs, the report states.
The vote followed an extensive campaign from both sides. Pharmaceutical industry-backed opponents to the ballot initiative argued most Ohioans could see drug prices rise if the measure passed due to the possible shift of drug costs from drug companies to Medicare patients and the privately insured, according to STAT. Supporters of the ballot initiative referenced rising drug prices and the relationship between the pharmaceutical industry and the opioid epidemic as part of their effort to garner “yes” votes.
In the end, the report states many voters said the messages from both sides left things unclear as far as the ballot initiative’s details and its potential impact.
More articles on supply chain:
Dr. Scott Gottlieb: FDA to accelerate approval for direct-to-consumer genetic tests
Surescripts partners with EHR vendors, PBMs to promote drug price transparency
2.3k Eli Lilly employees accept buyouts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
